Literature DB >> 17192959

Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.

Sofia Halin1, Peter Hammarsten, Pernilla Wikström, Anders Bergh.   

Abstract

BACKGROUND: Castration-induced involution of the normal prostate is caused by primary effects in the prostate stroma and vasculature, but if this is the case also in tumors is unknown.
METHODS: Androgen-independent AT-1 prostate tumor cells were therefore injected into the ventral prostate (VP) in Copenhagen rats. Seven days later when the growing tumor was surrounded by normal VP tissue the rats were castrated and the effect examined 3 and 7 days later.
RESULTS: Castration reduced vascular density in the surrounding VP tissue and this was accompanied by tumor cell hypoxia, apoptosis, and temporarily retarded tumor growth. Castration-induced VP tissue regression occurred more rapidly in the contra-lateral than in the tumor-bearing lobe.
CONCLUSIONS: Androgen-independent tumor cell respond to castration when growing in an androgen-dependent environment. The presence of a tumor influences the castration response in the surrounding normal tissue. The microenvironment determines how prostate epithelial cells respond to castration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17192959     DOI: 10.1002/pros.20473

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  31 in total

Review 1.  Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.

Authors:  Simeng Wen; Yuanjie Niu; Soo Ok Lee; Chawnshang Chang
Journal:  Cancer Treat Rev       Date:  2013-08-07       Impact factor: 12.111

2.  Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.

Authors:  Elena V Fernandez; Kelie M Reece; Ariel M Ley; Sarah M Troutman; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

3.  Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment.

Authors:  Sofia Halin; Stina Häggström Rudolfsson; Jennifer A Doll; Susan E Crawford; Pernilla Wikström; Anders Bergh
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

4.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.

Authors:  You-Yi Lu; Bo Jiang; Fu-Jun Zhao; Di Cui; Qi Jiang; Jun-Jie Yu; En-Hui Li; Xiao-Hai Wang; Bang-Min Han; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2013-06-24       Impact factor: 3.285

6.  Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.

Authors:  Gagan Deep; Rahul Kumar; Dhanya K Nambiar; Anil K Jain; Anand M Ramteke; Natalie J Serkova; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2016-09-05       Impact factor: 4.784

7.  Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.

Authors:  Andreas Josefsson; Hani Adamo; Peter Hammarsten; Torvald Granfors; Pär Stattin; Lars Egevad; Anna Engström Laurent; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

8.  Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.

Authors:  Sofia Halin; Stina Häggström Rudolfsson; Nico Van Rooijen; Anders Bergh
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

9.  Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.

Authors:  Christina Hägglöf; Peter Hammarsten; Andreas Josefsson; Pär Stattin; Janna Paulsson; Anders Bergh; Arne Ostman
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

10.  Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.

Authors:  Takeshi Sasaki; Kenichiro Ishii; Yoichi Iwamoto; Manabu Kato; Manabu Miki; Hideki Kanda; Kiminobu Arima; Taizo Shiraishi; Yoshiki Sugimura
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.